A citation-based method for searching scientific literature

Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh. Diabetes 2009
Times Cited: 76



J Zhang, Y Tokui, K Yamagata, J Kozawa, K Sayama, H Iwahashi, K Okita, M Miuchi, H Konya, T Hamaguchi, M Namba, I Shimomura, J-I Miyagawa. Diabetologia 2007
Times Cited: 55




List of shared articles



Times cited

Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.
A E Hogan, A M Tobin, T Ahern, M A Corrigan, G Gaoatswe, R Jackson, V O'Reilly, L Lynch, D G Doherty, P N Moynagh,[...]. Diabetologia 2011
86

Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass.
Bernard Portha, Cécile Tourrel-Cuzin, Jamileh Movassat. Exp Diabetes Res 2011
46


Use of glucagon-like peptide-1 agonists to improve islet graft performance.
Yong Wang, Meirigeng Qi, James J McGarrigle, Brian Rady, Maureen E Davis, Pilar Vaca, Jose Oberholzer. Curr Diab Rep 2013
7


The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
37